Adma Biologics reported $83.82M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Adma Biologics USD 83.82M 11.49M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Dynavax Technologies USD 260.51M 36.65M Mar/2025
Takeda JPY 4.51T 9.32B Jun/2025